Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 52Unknown 20Recruiting 16Not yet recruiting 12Active not recruiting 9Withdrawn 2Terminated 2Suspended 1Enrolling by invitation 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 1132Triple Negative Breast Neoplasms 148Neoplasm Metastasis 99Carcinoma, Non-Small-Cell Lung 85Ovarian Neoplasms 81Neoplasms 75Lung Neoplasms 64Colorectal Neoplasms 60Melanoma 59Stomach Neoplasms 44Pancreatic Neoplasms 43Breast Neoplasms, Male 43Prostatic Neoplasms 42Carcinoma, Renal Cell 37Squamous Cell Carcinoma of Head and Neck 35Sarcoma 30Colonic Neoplasms 29Endometrial Neoplasms 28Head and Neck Neoplasms 26Brain Neoplasms 24Urinary Bladder Neoplasms 22Esophageal Neoplasms 21Carcinoma, Ovarian Epithelial 21Carcinoma, Intraductal, Noninfiltrating 21Lymphoma, Non-Hodgkin 19Recurrence 18Uterine Cervical Neoplasms 17Inflammatory Breast Neoplasms 17Breast Carcinoma In Situ 17Multiple Myeloma 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Breast Cancer Lymphedema × Breast × Clear all
NCT02994771 2023-04-24

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Herantis Pharma Plc.

Phase 1 Terminated
15 enrolled
Breast

Breast Cancer Lymphedema

NCT04073823 2023-01-18

A Study Evaluating FT-SW in Unilateral Breast Cancer-Related Lymphedema Patients

Tactile Medical

Phase NA Terminated
2 enrolled 15 charts
Breast

Breast Cancer Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡